Justices Won't Revive Teva-IBSA Thyroid Drug Patent Fight
The U.S. Supreme Court won't consider overturning a Federal Circuit ruling that a patent on the thyroid drug Tirosint is invalid as indefinite, rebuffing a patent owner that said the ruling...To view the full article, register now.
Already a subscriber? Click here to view full article